Novabloc Overview

  • Year Founded
  • 2023

Year Founded

  • Status
  • Private

  • Employees
  • 5

Employees

  • Latest Deal Type
  • Series A

  • Latest Deal Amount
  • $10M

  • Investors
  • 5

Novabloc General Information

Description

Developer of a non opioid neuromodulation therapy designed to advance postsurgical pain management without dependence on narcotics. The company's platform offers targeted electrical stimulation, sustained analgesic effect, and preservation of motor control, enabling surgical patients and care teams improved recovery with reduced medication reliance.

Contact Information

Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Corporate Office
  • 223 Roswell Street
  • Alpharetta, GA 30009
  • United States
+1 (678)
Primary Industry
Therapeutic Devices
Other Industries
Biotechnology
Pharmaceuticals
Corporate Office
  • 223 Roswell Street
  • Alpharetta, GA 30009
  • United States
+1 (678)

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Novabloc Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
3. Early Stage VC (Series A) 18-Nov-2024 $10M Completed Clinical Trials - General
2. Accelerator/Incubator Completed Clinical Trials - General
1. Spin-Off 01-Jan-2023 Completed Clinical Trials - General
To view Novabloc’s complete valuation and funding history, request access »

Novabloc Cap Table

Stock # of Shares
Authorized
Par Value Dividend Rate (%) Original
Issue Price
Liquidation Liquidation
Pref. Multiple
Conversion Price % Owned
Series A
To view Novabloc’s complete cap table history, request access »

Novabloc Patents

Novabloc Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
US-11623091-B2 Portable electrical stimulation system and method Active 13-Feb-2019
US-20200254257-A1 Portable electrical stimulation system and method Active 13-Feb-2019
US-10828491-B2 Device and method to selectively and reversibly modulate a nervous system structure to inhibit pain Active 07-Dec-2018
US-11202909-B2 Device and method to selectively and reversibly modulate a nervous system structure to inhibit pain Active 07-Dec-2018
US-11446498-B2 Device and method to selectively and reversibly modulate a nervous system structure to inhibit pain Active 07-Dec-2018 A61N1/36071
To view Novabloc’s complete patent history, request access »

Novabloc Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Novabloc Investors (5)

Investor Name Investor Type Holding Investor Since Participating Rounds
Hatteras Venture Partners Venture Capital Minority
Portal Innovations Venture Capital Minority
UNC Health Ventures Corporate Venture Capital Minority
UNC REX Healthcare Corporation Minority
Tech North Atlanta Accelerator/Incubator
To view Novabloc’s complete investors history, request access »

Novabloc FAQs

  • When was Novabloc founded?

    Novabloc was founded in 2023.

  • Where is Novabloc headquartered?

    Novabloc is headquartered in Alpharetta, GA.

  • What is the size of Novabloc?

    Novabloc has 5 total employees.

  • What industry is Novabloc in?

    Novabloc’s primary industry is Therapeutic Devices.

  • Is Novabloc a private or public company?

    Novabloc is a Private company.

  • What is the current valuation of Novabloc?

    The current valuation of Novabloc is .

  • What is Novabloc’s current revenue?

    The current revenue for Novabloc is .

  • How much funding has Novabloc raised over time?

    Novabloc has raised $10M.

  • Who are Novabloc’s investors?

    Hatteras Venture Partners, Portal Innovations, UNC Health Ventures, UNC REX Healthcare, and Tech North Atlanta have invested in Novabloc.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process